Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

9821 - 9830 von 9869

	9821	Zinc in Preventing the Progression of pre-Diabetes (ZIPPeD Study) – study protocol for a randomised placebo-controlled trial in Australia Enthalten in Trials Bd. 20, 15.4.2019, Nr. 1, date:12.2019: 1-8
	9822	Zinc supplementation affects favorably the frequency of migraine attacks: a double-blind randomized placebo-controlled clinical trial Enthalten in Nutrition journal Bd. 19, 14.9.2020, Nr. 1, date:12.2020: 1-8
	9823	Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial Enthalten in Diabetology & metabolic syndrome Bd. 11, 2.12.2019, Nr. 1, date:12.2019: 1-10
	9824	Zirkulierende DNA als Prognosemarker Enthalten in InFo Onkologie Bd. 22, 9.2.2019, Nr. 1-2, date:2.2019: 37
	9825	Zoledronsäure beim metastasierten Mammakarzinom Enthalten in Im Focus Onkologie Bd. 21, 6.3.2018, Nr. 3, date:3.2018: 63
	9826	Zoledronsäure: Ist q12w so wirksam wie q4w? Enthalten in InFo Onkologie Bd. 20, 2.11.2017, Nr. 7, date:11.2017: 24-26
	9827	Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial Enthalten in Supportive care in cancer Bd. 31, 19.12.2022, Nr. 1, date:1.2023: 1-9
	9828	Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial Enthalten in Trials Bd. 19, 27.12.2018, Nr. 1, date:12.2018: 1-9
	9829	Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia Enthalten in Psychopharmacology Bd. 150, 1.6.2000, Nr. 3, date:6.2000: 237-243
	9830	ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial Enthalten in Nature Communications Bd. 14, 12.10.2023, Nr. 1, date:12.2023: 1-11